Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The Purpose of this trial is:
- to determine complete response rate (CRR) after six cycles of chemotherapy
- to determine complete remission rate (CR/CRr) as final treatment outcome after
completion of treatment